Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

FCN vs ACCL: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

FCN Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 8–2 Matrix Metrics)

FCN Overall Winner 6-Pillar Tally: FCN 5 – 1 ACCL Matrix Metrics: FCN 8 – 2 ACCL

As of Nov 16, 2026, FTI Consulting, Inc. (FCN) is the stronger overall head-to-head candidate over ACCL (ACCL) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). FCN carries a Unified Composite Score of 27.4/100 (SELL) at $206.76 (18.2x Forward P/E, 10.3% operating margin), whereas ACCL carries 63.4/100 (BUY) at $2.36 (N/M Forward P/E, 4.5% operating margin).

  • Composite vs. Pillar Nuance: While ACCL currently prints a higher short-term Unified Composite Score (63.4/100 BUY vs. FCN 27.4/100 SELL), FCN captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (10.3% vs. 4.5% operating margin) and revenue trajectory (+5.9% vs. +11.3% YoY).
  • Technical & Structure Timing Caution: FCN trades in a Markup technical trend (SURGE options phase, RSI 84.1); meanwhile ACCL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About FCN vs ACCL
FCN NYSE Head-to-Head Winner
FTI Consulting, Inc.
Services-Management Consulting Services
$206.76
+1.95% 1D
Market Cap $5.4B
TTM Revenue $3.98B
Forward P/E 18.2x
Beta / 30D Vol -0.49β · 54% Vol
Unified Composite Score
27.4 / 100 SELL
Tech 50.0 Fund 34.0 Flow 68.0 Mom 40.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (8.0% over 20 days), RSI 84
RSI-14: 84.1 · SMA20: $181.50 · SMA50: $157.10
ACCL US Equity
ACCL
Institutional Equity
$2.36
-0.84% 1D
Market Cap $33.5M
TTM Revenue $5.2M
Forward P/E N/M
Beta / 30D Vol -0.20β · 60% Vol
Unified Composite Score
63.4 / 100 BUY
Tech 68.0 Fund 58.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -4.9%), weak momentum, RSI 39
RSI-14: 39.2 · SMA20: $2.54 · SMA50: $2.65

6-Pillar Scorecard Institutional Category Breakdown (FCN 5 – 1 ACCL)

Columns: Metric · FCN · ACCL
1. Valuation Multiples FCN
Forward P/E 18.2x N/M
Trailing P/E 24.7x 120.0x
PEG Ratio 0.96x N/M
EV / Revenue 1.6x 6.5x
2. Growth & Scale FCN
Revenue Growth (YoY) +5.9% +11.3%
Earnings Growth (YoY) -9.6% -62.5%
TTM Revenue (USD) $3.98B $5.2M
Market Cap $5.4B $33.5M
3. Profitability & Quality FCN
Gross Margin 32.2% 42.4%
Operating Margin 10.3% 4.5%
Net Profit Margin 5.9% 5.5%
Return on Equity (ROE) 15.2% 7.0%
4. Balance Sheet & Cash Flow FCN
Cash Generation (TTM) $354M $245,425 EBITDA
Cash Flow Margin 8.9% 4.7% EBITDA Mgn
Net Cash / Leverage $960M Net Debt (0.79x D/E) $0.43 Book/Sh · 7.0% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning FCN
Options Structure Phase SURGE UNCLASSIFIED
Current IV / %ile 36.9% (8th %ile) N/A (N/A)
Put/Call OI Skew 1.33x (Put-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Markup NEUTRAL · Markdown
6. R&D & Supply-Chain Moat ACCL
OpEx & R&D Intensity 21.9% of Rev ($872M) 37.9% of Rev ($2.0M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Consulting Services Operator Consulting Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: FCN (8) vs ACCL (2)
Institutional Metric FCN ACCL Criterion Row Edge
Market Capitalization
Scale
$5.4B $33.5M Larger Scale FCN
Trailing P/E Ratio
Valuation
24.7x 120.0x Lower Multiple FCN
Forward P/E Ratio
Valuation
18.2x N/M Lower Multiple FCN
Revenue Growth (YoY)
Growth
+5.9% +11.3% Higher Growth ACCL
Operating Margin (TTM)
Profitability
10.3% 4.5% Higher Margin FCN
Net Profit Margin
Profitability
5.9% 5.5% Higher Margin FCN
Return on Equity (ROE)
Capital Efficiency
15.2% 7.0% Higher ROE FCN
52-Week Range Position
Momentum
98% ($129–$209) 30% ($1–$5) Stronger Trend FCN
Beta / 30D Volatility
Risk Regime
-0.49β · 54% Vol -0.20β · 60% Vol Lower Realized Risk FCN
Unified Institutional Score
Composite Signal
27.4 / 100 (SELL) 63.4 / 100 (BUY) Higher Composite ACCL
Trailing 12M Revenue (USD)
Operating Scale
$3.98B $5.2M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
32.2% 42.4% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.96x PEG · 1.6x EV/Rev N/M PEG · 6.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$354M ($960M Net Debt (0.79x D/E)) $245,425 EBITDA ($0.43 Book/Sh · 7.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon FCN +59.85 pp
FCN: +47.59% · ACCL: -12.26%
3M Horizon FCN +53.06 pp
FCN: +36.16% · ACCL: -16.9%
6M Horizon ACCL +19.95 pp
FCN: +40.6% · ACCL: +60.55%
1Y Horizon FCN +69.01 pp
FCN: +25.34% · ACCL: -43.67%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FCN vs ACCL. Trailing 12-month operating profitability (FCN 10.3% vs ACCL 4.5%) and valuation multiples (FCN 18.2x vs ACCL N/M Forward P/E) are benchmarked directly in Pillar 4 below.

FCN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$3.98B
Gross Margin32.2%
Op. Margin10.3%
ROE / Fwd P/E15.2% · 18.2x
ACCL ADR TTM Benchmark FX-Normalized USD
TTM Revenue$5.2M
Gross Margin42.4%
Op. Margin4.5%
ROE / Fwd P/E7.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
FCN SURGE
8d in phase · OBV DISTRIBUTION
Current IV 36.9%
IV Percentile 8th %ile
Put/Call OI Skew 1.33x (Put-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact FCN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ACCL UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ACCL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
FCN Moat Profile Cyclical / Execution-Driven Positioning
Consulting Services Operator
Competes within the Consulting Services value chain with $5.4B market capitalization and 10.3% operating margin.
OpEx & R&D Reinvestment 21.9% of Rev ($872M)
90D Engineering Disclosures 0 Published
ACCL Moat Profile Cyclical / Execution-Driven Positioning
Consulting Services Operator
Competes within the Consulting Services value chain with $33.5M market capitalization and 4.5% operating margin.
OpEx & R&D Reinvestment 37.9% of Rev ($2.0M)
90D Engineering Disclosures 0 Published

Investor FAQ FCN vs ACCL Key Questions & Quantitative Answers

As of Nov 16, 2026, FTI Consulting, Inc. (FCN) is the stronger overall head-to-head candidate over ACCL (ACCL) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). FCN carries a Unified Composite Score of 27.4/100 (SELL) at $206.76 (18.2x Forward P/E, 10.3% operating margin), whereas ACCL carries 63.4/100 (BUY) at $2.36 (N/M Forward P/E, 4.5% operating margin). Composite vs. Pillar Nuance: While ACCL currently prints a higher short-term Unified Composite Score (63.4/100 BUY vs. FCN 27.4/100 SELL), FCN captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (10.3% vs. 4.5% operating margin) and revenue trajectory (+5.9% vs. +11.3% YoY). Technical & Structure Timing Caution: FCN trades in a Markup technical trend (SURGE options phase, RSI 84.1); meanwhile ACCL is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 39.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

FCN leads the Growth & Scale pillar: FCN posts +5.9% YoY revenue growth and -9.6% YoY earnings growth on $3.98B TTM revenue (32.2% gross margin, 10.3% operating margin), compared with ACCL at +11.3% YoY revenue growth and -62.5% YoY earnings growth on $5.2M TTM revenue (42.4% gross margin, 4.5% operating margin). On trailing 12-month operating scale, FCN generates $3.98B in USD-normalized revenue versus $5.2M for ACCL. In operating R&D and SG&A reinvestment, FCN deploys 21.9% of Rev ($872M) (0 90-day corporate R&D disclosures) versus 37.9% of Rev ($2.0M) (0 disclosures) for ACCL.

FCN screens cheaper on headline valuation multiples. FCN trades at 18.2x Forward P/E, 24.7x Trailing P/E, 0.96x PEG, and 1.6x EV/Revenue (8.9% FCF margin), whereas ACCL trades at N/M Forward P/E, 120.0x Trailing P/E, N/M PEG, and 6.5x EV/Revenue (4.7% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against FCN (15.2% ROE) versus ACCL (7.0% ROE) capital efficiency.

In options market volatility and institutional positioning, FCN carries 36.9% implied volatility (8th %ile, Compressed (<25th %ile)), a 1.33x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a SURGE options structure phase (-0.49β · 54% Vol realized risk). By comparison, ACCL carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.20β · 60% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.